Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency.
Luca BarresiMatteo TacelliStefano Francesco CrinòFabia AttiliMaria Chiara PetroneGermana De NucciSilvia CarraraGuido ManfrediGabriele CapursoClaudio Giovanni De AngelisLucia CrocellàAlberto FantinMaria Francesca DoreAlessandra Tina GarribbaIlaria TarantinoNicolò De PretisDanilo PagliariGemma RossiGianpiero ManesPaoletta PreatoniIlenia BarbuscioFabio TuzzolinoMario TrainaLuca FrulloniGuido CostamagnaPaolo Giorgio ArcidiaconoElisabetta BuscariniRaffaele Pezzillinull nullPublished in: United European gastroenterology journal (2020)
In this cohort of AIP patients, diagnosis and classification for subtype was frequently possible, confirming the different characteristics of AIP1 and AIP2 previously reported. Nevertheless, we observed a low use of histology and steroid trial for a diagnosis of AIP. Steroid treatment was the most used therapy in our cohort. Immunosuppressants and rituximab were rarely used. The evaluation of exocrine pancreatic insufficiency is underemployed considering its high prevalence.
Keyphrases
- end stage renal disease
- healthcare
- multiple sclerosis
- machine learning
- chronic kidney disease
- newly diagnosed
- ejection fraction
- clinical trial
- deep learning
- randomized controlled trial
- diffuse large b cell lymphoma
- electronic health record
- combination therapy
- patient reported outcomes
- peritoneal dialysis
- big data
- artificial intelligence
- data analysis
- drug induced
- chronic lymphocytic leukemia
- smoking cessation